Blockchain Registration Transaction Record
Lexaria Bioscience to Showcase DehydraTECH at BIO 2025
Lexaria Bioscience Corp. to attend BIO 2025, showcasing DehydraTECH® technology for enhanced drug delivery. A leap forward in treating diabetes, hypertension, and more.

Lexaria Bioscience's participation in the BIO International Convention highlights the potential for groundbreaking advancements in drug delivery technology. Their DehydraTECH® platform could revolutionize how medications are absorbed, offering more effective treatments with fewer side effects for conditions like diabetes and hypertension. This development is crucial for patients seeking better therapeutic options and for investors looking for innovative healthcare solutions.
Blockchain | Details |
---|---|
Contract Address | 0xeA2912a8DA1CD48401b10cB283585874d98098F4 |
Transaction ID | 0xe22dcb26534a037352b8d4912003b0f3c3ce523b3467c735dd5203ac6af09d5d |
Account | 0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20 |
Chain | polygon-main |
NewsRamp Digital Fingerprint | glowYk2D-cb5c7df396e105be98ced83171c71b56 |